October 2016. Volume 12. Number 3

Does the use of nasal CPAP mask reduce the risk of bronchopulmonary dysplasia in premature infants?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Say B, Kanmaz Kutman HG, Oguz SS, Oncel MY, Arayici S, Canpolat FE, et al. Binasal prong versus nasal mask for applying CPAP to preterm infants: A randomized controlled trial. Neonatology. 2016;109:258-64.

Reviewers: Carvajal Encina F1, Rivas Fernández MÁ2.
1UCIN Hospital de La Serena y Escuela de Medicina Universidad Católica del Norte. La Serena. Elqui. Chile.
2Hospital General de Cataluña. Sant Cugat del Vallés. Barcelona. España.
Correspondence: Fernando Carvajal Encina. Email: fcarvajal@ucn.cl
Reception date: 23/07/2016
Acceptance date: 29/08/2016
Publication date: 07/09/2016

Abstract

Authors’ conclusions: applying CPAP by means of a nasal mask significantly shortens its duration and reduces the rates of moderate and severe bronchopulmonary dysplasia in preterm newborns.

Reviewers’ commentary: the study has methodological limitations; therefore the conclusions of the authors do not seem applicable.

Key words: bronchopulmonary dysplasia; continuous positive airway pressure; infant, premature; clinical trial.

How to cite this article

Carvajal Encina F, Rivas Fernández MA. ¿El uso de máscara nasal en CPAP reduce el riesgo de displasia broncopulmonar en prematuros? Evid Pediatr. 2016;12:44.

AVC | Critically appraised articles

Say B, Kanmaz Kutman HG, Oguz SS, Oncel MY, Arayici S, Canpolat FE, et al. Binasal prong versus nasal mask for applying CPAP to preterm infants: A randomized controlled trial. Neonatology. 2016;109:258-64.

Reviewers: Carvajal Encina F1, Rivas Fernández MÁ2.
1UCIN Hospital de La Serena y Escuela de Medicina Universidad Católica del Norte. La Serena. Elqui. Chile.
2Hospital General de Cataluña. Sant Cugat del Vallés. Barcelona. España.
Correspondence: Fernando Carvajal Encina. Email: fcarvajal@ucn.cl
Reception date: 23/07/2016
Acceptance date: 29/08/2016
Publication date: 07/09/2016

How to cite this article

Carvajal Encina F, Rivas Fernández MA. ¿El uso de máscara nasal en CPAP reduce el riesgo de displasia broncopulmonar en prematuros? Evid Pediatr. 2016;12:44.

References

  1. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, et al. European CONSENSUS GUIDELINES ON THE MANAGEMENT OF NEONATAL RESPIRATORY DISTRESS SYNDROME IN PRETERM INFANTS - 2013 Update. Neonatology. 2013;103:353-68.
  2. De Paoli AG, Davis PG, Faber B, Morley CJ. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2008;(1):CD002977.
  3. Jensen EA, Foglia EE, Schmidt, B. Evidence-based pharmacologic therapies for prevention of bronchopulmonary dysplasia: application of the grading of recommendations assessment, development, and evaluation methodology. Clin Perinatol. 2015;42:755-79.
  4. Kanmaz HG, Erdeve O, Canpolat FE, Mutlu B, Dilmen U. Randomized controlled trial. Surfactant administration via thin catheter during spontaneous breathing. Pediatrics. 2013;131:e502-9.
  5. Kieran EA, Twomey AR, Molloy EJ, Murphy JF, O’Donnell CP. Randomized trial of prongs or mask for nasal continuous positive airway pressure in preterm infants. Pediatrics. 2012;130:e1170-6.
07/09/2016

Linked Comment